| Year |
Citation |
Score |
| 2017 |
Tong J, Rathitharan G, Meyer JH, Furukawa Y, Ang LC, Boileau I, Guttman M, Hornykiewicz O, Kish SJ. Brain monoamine oxidase B and A in human parkinsonian dopamine deficiency disorders. Brain : a Journal of Neurology. 140: 2460-2474. PMID 29050386 DOI: 10.1093/Brain/Awx172 |
0.507 |
|
| 2017 |
Sitte HH, Pifl C, Rajput AH, Hörtnagl H, Tong J, Lloyd GK, Kish SJ, Hornykiewicz O. Dopamine and noradrenaline, but not serotonin, in the human claustrum are greatly reduced in patients with Parkinson's disease: possible functional implications. The European Journal of Neuroscience. 45: 1356. PMID 28523903 DOI: 10.1111/ejn.13573 |
0.726 |
|
| 2017 |
Furukawa Y, Hornykiewicz O, Kish S. Characteristic neurochemical changes in the substantia nigra (SN) and striatum of symptomatic versus asymptomatic dopa-responsive dystonia (DRD) Journal of the Neurological Sciences. 381: 178. DOI: 10.1016/J.Jns.2017.08.515 |
0.331 |
|
| 2016 |
Sitte HH, Pifl C, Rajput AH, Hörtnagl H, Tong J, Lloyd GK, Kish SJ, Hornykiewicz O. Dopamine and noradrenaline, but not serotonin, in the human claustrum are greatly reduced in patients with Parkinson's disease: Possible functional implications. The European Journal of Neuroscience. PMID 27741357 DOI: 10.1111/Ejn.13435 |
0.755 |
|
| 2016 |
Furukawa Y, Rajput AH, Tong J, Tomizawa Y, Hornykiewicz O, Kish SJ. A marked contrast between serotonergic and dopaminergic changes in dopa-responsive dystonia. Neurology. PMID 27488599 DOI: 10.1212/Wnl.0000000000003065 |
0.428 |
|
| 2015 |
Tong J, Ang LC, Williams B, Furukawa Y, Fitzmaurice P, Guttman M, Boileau I, Hornykiewicz O, Kish SJ. Low levels of astroglial markers in Parkinson's disease: relationship to α-synuclein accumulation. Neurobiology of Disease. 82: 243-253. PMID 26102022 DOI: 10.1016/J.Nbd.2015.06.010 |
0.438 |
|
| 2015 |
Pifl C, Reither H, Hornykiewicz O. The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter. European Journal of Pharmacology. 755: 119-26. PMID 25771452 DOI: 10.1016/J.Ejphar.2015.03.004 |
0.692 |
|
| 2014 |
Pifl C, Rajput A, Reither H, Blesa J, Cavada C, Obeso JA, Rajput AH, Hornykiewicz O. Is Parkinson's disease a vesicular dopamine storage disorder? Evidence from a study in isolated synaptic vesicles of human and nonhuman primate striatum. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 8210-8. PMID 24920625 DOI: 10.1523/Jneurosci.5456-13.2014 |
0.763 |
|
| 2013 |
Pifl C, Hornykiewicz O, Blesa J, Adánez R, Cavada C, Obeso JA. Reduced noradrenaline, but not dopamine and serotonin in motor thalamus of the MPTP primate: relation to severity of parkinsonism. Journal of Neurochemistry. 125: 657-62. PMID 23331162 DOI: 10.1111/Jnc.12162 |
0.699 |
|
| 2012 |
Pifl C, Kish SJ, Hornykiewicz O. Thalamic noradrenaline in Parkinson's disease: deficits suggest role in motor and non-motor symptoms. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 1618-24. PMID 23038412 DOI: 10.1002/Mds.25109 |
0.671 |
|
| 2012 |
Blesa J, Pifl C, Sánchez-González MA, Juri C, García-Cabezas MA, Adánez R, Iglesias E, Collantes M, Peñuelas I, Sánchez-Hernández JJ, Rodríguez-Oroz MC, Avendaño C, Hornykiewicz O, Cavada C, Obeso JA. The nigrostriatal system in the presymptomatic and symptomatic stages in the MPTP monkey model: a PET, histological and biochemical study. Neurobiology of Disease. 48: 79-91. PMID 22677034 DOI: 10.1016/J.Nbd.2012.05.018 |
0.746 |
|
| 2011 |
Peneder TM, Scholze P, Berger ML, Reither H, Heinze G, Bertl J, Bauer J, Richfield EK, Hornykiewicz O, Pifl C. Chronic exposure to manganese decreases striatal dopamine turnover in human alpha-synuclein transgenic mice. Neuroscience. 180: 280-92. PMID 21333719 DOI: 10.1016/J.Neuroscience.2011.02.017 |
0.688 |
|
| 2011 |
Tong J, Furukawa Y, Sherwin A, Hornykiewicz O, Kish SJ. Heterogeneous intrastriatal pattern of proteins regulating axon growth in normal adult human brain. Neurobiology of Disease. 41: 458-68. PMID 21029775 DOI: 10.1016/J.Nbd.2010.10.017 |
0.44 |
|
| 2011 |
Ouattara B, Grégoire L, Morissette M, Gasparini F, Vranesic I, Bilbe G, Johns DR, Rajput A, Hornykiewicz O, Rajput AH, Gomez-Mancilla B, Di Paolo T. Metabotropic glutamate receptor type 5 in levodopa-induced motor complications. Neurobiology of Aging. 32: 1286-95. PMID 20036444 DOI: 10.1016/J.Neurobiolaging.2009.07.014 |
0.327 |
|
| 2010 |
Hornykiewicz O. A brief history of levodopa. Journal of Neurology. 257: S249-52. PMID 21080185 DOI: 10.1007/s00415-010-5741-y |
0.557 |
|
| 2010 |
Peneder TM, Berger M, Scholze P, Heinze G, Bertl J, Bauer J, Hornykiewicz O, Richfield EK, Pifl C. Interaction of manganese with striatal dopamine turnover in human alpha-synuclein transgenic mice Bmc Pharmacology. 10. DOI: 10.1186/1471-2210-10-S1-A16 |
0.675 |
|
| 2009 |
Samadi P, Rajput A, Calon F, Grégoire L, Hornykiewicz O, Rajput AH, Di Paolo T. Metabotropic glutamate receptor II in the brains of Parkinsonian patients. Journal of Neuropathology and Experimental Neurology. 68: 374-82. PMID 19287314 DOI: 10.1097/NEN.0b013e31819cabe4 |
0.419 |
|
| 2009 |
Boileau I, Guttman M, Rusjan P, Adams JR, Houle S, Tong J, Hornykiewicz O, Furukawa Y, Wilson AA, Kapur S, Kish SJ. Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson's disease. Brain : a Journal of Neurology. 132: 1366-75. PMID 19153147 DOI: 10.1093/Brain/Awn337 |
0.454 |
|
| 2008 |
Hornykiewicz O. Basic research on dopamine in Parkinson's disease and the discovery of the nigrostriatal dopamine pathway: the view of an eyewitness. Neuro-Degenerative Diseases. 5: 114-7. PMID 18322366 DOI: 10.1159/000113678 |
0.596 |
|
| 2008 |
Rajput AH, Sitte HH, Rajput A, Fenton ME, Pifl C, Hornykiewicz O. Globus pallidus dopamine and Parkinson motor subtypes: clinical and brain biochemical correlation. Neurology. 70: 1403-10. PMID 18172064 DOI: 10.1212/01.Wnl.0000285082.18969.3A |
0.744 |
|
| 2008 |
Kish SJ, Tong J, Hornykiewicz O, Rajput A, Chang LJ, Guttman M, Furukawa Y. Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease. Brain : a Journal of Neurology. 131: 120-31. PMID 17956909 DOI: 10.1093/Brain/Awm239 |
0.592 |
|
| 2007 |
Tong J, Hornykiewicz O, Furukawa Y, Kish SJ. Marked dissociation between high noradrenaline versus low noradrenaline transporter levels in human nucleus accumbens. Journal of Neurochemistry. 102: 1691-702. PMID 17484728 DOI: 10.1111/J.1471-4159.2007.04636.X |
0.457 |
|
| 2006 |
Tong J, Hornykiewicz O, Kish SJ. Inverse relationship between brain noradrenaline level and dopamine loss in Parkinson disease: a possible neuroprotective role for noradrenaline. Archives of Neurology. 63: 1724-8. PMID 17172611 DOI: 10.1001/Archneur.63.12.1724 |
0.529 |
|
| 2006 |
Hornykiewicz O. The discovery of dopamine deficiency in the parkinsonian brain. Journal of Neural Transmission. Supplementum. 9-15. PMID 17017502 |
0.48 |
|
| 2006 |
Pifl C, Hornykiewicz O. Dopamine turnover is upregulated in the caudate/putamen of asymptomatic MPTP-treated rhesus monkeys. Neurochemistry International. 49: 519-24. PMID 16698121 DOI: 10.1016/J.Neuint.2006.03.013 |
0.765 |
|
| 2006 |
Tong J, Hornykiewicz O, Kish SJ. Identification of a noradrenaline-rich subdivision of the human nucleus accumbens. Journal of Neurochemistry. 96: 349-54. PMID 16336226 DOI: 10.1111/J.1471-4159.2005.03546.X |
0.5 |
|
| 2005 |
Woldman I, Reither H, Kattinger A, Hornykiewicz O, Pifl C. Dopamine inhibits cell growth and cell cycle by blocking ribonucleotide reductase. Neuropharmacology. 48: 525-37. PMID 15755480 DOI: 10.1016/J.Neuropharm.2004.11.013 |
0.723 |
|
| 2004 |
Olanow CW, Agid Y, Mizuno Y, Albanese A, Bonuccelli U, Bonucelli U, Damier P, De Yebenes J, Gershanik O, Guttman M, Grandas F, Hallett M, Hornykiewicz O, Jenner P, Katzenschlager R, et al. Levodopa in the treatment of Parkinson's disease: current controversies. Movement Disorders : Official Journal of the Movement Disorder Society. 19: 997-1005. PMID 15372588 DOI: 10.1002/Mds.20243 |
0.414 |
|
| 2004 |
Rajput AH, Fenton ME, Di Paolo T, Sitte H, Pifl C, Hornykiewicz O. Human brain dopamine metabolism in levodopa-induced dyskinesia and wearing-off. Parkinsonism & Related Disorders. 10: 221-6. PMID 15120096 DOI: 10.1016/J.Parkreldis.2004.01.004 |
0.741 |
|
| 2004 |
Calon F, Dridi M, Hornykiewicz O, Bédard PJ, Rajput AH, Di Paolo T. Increased adenosine A2A receptors in the brain of Parkinson's disease patients with dyskinesias. Brain : a Journal of Neurology. 127: 1075-84. PMID 15033896 DOI: 10.1093/brain/awh128 |
0.322 |
|
| 2004 |
Pifl C, Khorchide M, Kattinger A, Reither H, Hardy J, Hornykiewicz O. alpha-Synuclein selectively increases manganese-induced viability loss in SK-N-MC neuroblastoma cells expressing the human dopamine transporter. Neuroscience Letters. 354: 34-7. PMID 14698476 DOI: 10.1016/J.Neulet.2003.09.064 |
0.672 |
|
| 2003 |
Calon F, Rajput AH, Hornykiewicz O, Bédard PJ, Di Paolo T. Levodopa-induced motor complications are associated with alterations of glutamate receptors in Parkinson's disease. Neurobiology of Disease. 14: 404-16. PMID 14678757 DOI: 10.1016/j.nbd.2003.07.003 |
0.464 |
|
| 2003 |
Haycock JW, Becker L, Ang L, Furukawa Y, Hornykiewicz O, Kish SJ. Marked disparity between age-related changes in dopamine and other presynaptic dopaminergic markers in human striatum. Journal of Neurochemistry. 87: 574-85. PMID 14535941 DOI: 10.1046/J.1471-4159.2003.02017.X |
0.419 |
|
| 2003 |
Calon F, Morissette M, Rajput AH, Hornykiewicz O, Bédard PJ, Di Paolo T. Changes of GABA receptors and dopamine turnover in the postmortem brains of parkinsonians with levodopa-induced motor complications. Movement Disorders : Official Journal of the Movement Disorder Society. 18: 241-53. PMID 12621627 DOI: 10.1002/mds.10343 |
0.498 |
|
| 2002 |
Hornykiewicz O. L-DOPA: from a biologically inactive amino acid to a successful therapeutic agent. Amino Acids. 23: 65-70. PMID 12373520 DOI: 10.1007/s00726-001-0111-9 |
0.303 |
|
| 2002 |
Pifl C, Kattinger A, Reither H, Hornykiewicz O. Cellular effects of dopamine--beyond oxidative mechanisms. Parkinsonism & Related Disorders. 8: 433-7. PMID 12217632 DOI: 10.1016/S1353-8020(02)00028-7 |
0.68 |
|
| 2002 |
Hornykiewicz O. Dopamine miracle: from brain homogenate to dopamine replacement. Movement Disorders : Official Journal of the Movement Disorder Society. 17: 501-8. PMID 12112197 DOI: 10.1002/mds.10115 |
0.473 |
|
| 2002 |
Calon F, Birdi S, Rajput AH, Hornykiewicz O, Bédard PJ, Di Paolo T. Increase of preproenkephalin mRNA levels in the putamen of Parkinson disease patients with levodopa-induced dyskinesias. Journal of Neuropathology and Experimental Neurology. 61: 186-96. PMID 11853020 |
0.363 |
|
| 2001 |
Tekumalla PK, Calon F, Rahman Z, Birdi S, Rajput AH, Hornykiewicz O, Di Paolo T, Bédard PJ, Nestler EJ. Elevated levels of DeltaFosB and RGS9 in striatum in Parkinson's disease. Biological Psychiatry. 50: 813-6. PMID 11720701 DOI: 10.1016/S0006-3223(01)01234-3 |
0.55 |
|
| 2001 |
Hornykiewicz O. Dopamine and Parkinson's disease. A personal view of the past, the present, and the future. Advances in Neurology. 86: 1-11. PMID 11553966 |
0.43 |
|
| 2001 |
Pifl C, Zezula J, Spittler A, Kattinger A, Reither H, Caron MG, Hornykiewicz O. Antiproliferative action of dopamine and norepinephrine in neuroblastoma cells expressing the human dopamine transporter. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 15: 1607-9. PMID 11427501 DOI: 10.1096/Fj.00-0738Fje |
0.744 |
|
| 2000 |
Furukawa Y, Hornykiewicz O, Fahn S, Kish SJ. Striatal dopamine in early-onset primary torsion dystonia with the DYT1 mutation. Neurology. 54: 1193-5. PMID 10720299 DOI: 10.1212/Wnl.54.5.1193 |
0.422 |
|
| 1999 |
Furukawa Y, Nygaard TG, Gütlich M, Rajput AH, Pifl C, DiStefano L, Chang LJ, Price K, Shimadzu M, Hornykiewicz O, Haycock JW, Kish SJ. Striatal biopterin and tyrosine hydroxylase protein reduction in dopa-responsive dystonia. Neurology. 53: 1032-41. PMID 10496263 DOI: 10.1212/Wnl.53.5.1032 |
0.725 |
|
| 1998 |
Ehringer H, Hornykiewicz O. Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system. Parkinsonism & Related Disorders. 4: 53-7. PMID 18591088 DOI: 10.1016/S1353-8020(98)00012-1 |
0.37 |
|
| 1998 |
Hornykiewicz O. Biochemical aspects of Parkinson's disease. Neurology. 51: S2-9. PMID 9711973 |
0.529 |
|
| 1996 |
Wilson JM, Levey AI, Rajput A, Ang L, Guttman M, Shannak K, Niznik HB, Hornykiewicz O, Pifl C, Kish SJ. Differential changes in neurochemical markers of striatal dopamine nerve terminals in idiopathic Parkinson's disease. Neurology. 47: 718-26. PMID 8797470 DOI: 10.1212/Wnl.47.3.718 |
0.748 |
|
| 1996 |
Pifl C, Hornykiewicz O, Giros B, Caron MG. Catecholamine transporters and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: studies comparing the cloned human noradrenaline and human dopamine transporter. The Journal of Pharmacology and Experimental Therapeutics. 277: 1437-43. PMID 8667208 |
0.708 |
|
| 1995 |
Zhong XH, Haycock JW, Shannak K, Robitaille Y, Fratkin J, Koeppen AH, Hornykiewicz O, Kish SJ. Striatal dihydroxyphenylalanine decarboxylase and tyrosine hydroxylase protein in idiopathic Parkinson's disease and dominantly inherited olivopontocerebellar atrophy. Movement Disorders : Official Journal of the Movement Disorder Society. 10: 10-7. PMID 7885342 DOI: 10.1002/Mds.870100104 |
0.482 |
|
| 1995 |
Pifl C, Drobny H, Reither H, Hornykiewicz O, Singer EA. Mechanism of the dopamine-releasing actions of amphetamine and cocaine: plasmalemmal dopamine transporter versus vesicular monoamine transporter. Molecular Pharmacology. 47: 368-73. PMID 7870046 |
0.687 |
|
| 1994 |
Shannak K, Rajput A, Rozdilsky B, Kish S, Gilbert J, Hornykiewicz O. Noradrenaline, dopamine and serotonin levels and metabolism in the human hypothalamus: observations in Parkinson's disease and normal subjects. Brain Research. 639: 33-41. PMID 8180836 DOI: 10.1016/0006-8993(94)91761-2 |
0.441 |
|
| 1994 |
Hornykiewicz O, Shannak K. Brain monoamines in progressive supranuclear palsy--comparison with idiopathic Parkinson's disease. Journal of Neural Transmission. Supplementum. 42: 219-27. PMID 7964689 |
0.461 |
|
| 1994 |
Rajput AH, Gibb WR, Zhong XH, Shannak KS, Kish S, Chang LG, Hornykiewicz O. Dopa-responsive dystonia: pathological and biochemical observations in a case. Annals of Neurology. 35: 396-402. PMID 7908789 DOI: 10.1002/Ana.410350405 |
0.47 |
|
| 1993 |
Hornykiewicz O. Parkinson's disease and the adaptive capacity of the nigrostriatal dopamine system: possible neurochemical mechanisms. Advances in Neurology. 60: 140-7. PMID 8420131 |
0.458 |
|
| 1992 |
Kish SJ, Shannak K, Rajput A, Deck JH, Hornykiewicz O. Aging produces a specific pattern of striatal dopamine loss: implications for the etiology of idiopathic Parkinson's disease. Journal of Neurochemistry. 58: 642-8. PMID 1729408 DOI: 10.1111/J.1471-4159.1992.Tb09766.X |
0.478 |
|
| 1992 |
Pifl C, Reither H, Hornykiewicz O. Functional sensitization of striatal dopamine D1 receptors in the 6-hydroxydopamine-lesioned rat. Brain Research. 572: 87-93. PMID 1535275 DOI: 10.1016/0006-8993(92)90455-I |
0.713 |
|
| 1992 |
Kish SJ, Mamelak M, Slimovitch C, Dixon LM, Lewis A, Shannak K, DiStefano L, Chang LJ, Hornykiewicz O. Brain neurotransmitter changes in human narcolepsy. Neurology. 42: 229-34. PMID 1370862 DOI: 10.1212/Wnl.42.1.229 |
0.544 |
|
| 1992 |
Pifl C, Schingnitz G, Hornykiewicz O. Striatal and non-striatal neurotransmitter changes in MPTP-parkinsonism in rhesus monkey: the symptomatic versus the asymptomatic condition. Neurochemistry International. 20: 295S-297S. PMID 1365445 DOI: 10.1016/0197-0186(92)90255-P |
0.695 |
|
| 1992 |
Pifl C, Nanoff C, Schingnitz G, Schütz W, Hornykiewicz O. Sensitization of dopamine-stimulated adenylyl cyclase in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated rhesus monkeys and patients with idiopathic Parkinson's disease. Journal of Neurochemistry. 58: 1997-2004. PMID 1349341 DOI: 10.1111/J.1471-4159.1992.Tb10939.X |
0.707 |
|
| 1992 |
Hornykiewicz O. Mechanisms of neuronal loss in Parkinson's disease: a neuroanatomical-biochemical perspective. Clinical Neurology and Neurosurgery. 94: S9-11. PMID 1320533 DOI: 10.1016/0303-8467(92)90008-Q |
0.456 |
|
| 1991 |
Pifl C, Reither H, Hornykiewicz O. Lower efficacy of the dopamine D1 agonist, SKF 38393, to stimulate adenylyl cyclase activity in primate than in rodent striatum. European Journal of Pharmacology. 202: 273-6. PMID 1839386 DOI: 10.1016/0014-2999(91)90304-9 |
0.696 |
|
| 1991 |
Kish SJ, Du F, Parks DA, Robitaille Y, Ball MJ, Schut L, Hornykiewicz O, Schwarcz R. Quinolinic acid catabolism is increased in cerebellum of patients with dominantly inherited olivopontocerebellar atrophy. Annals of Neurology. 29: 100-4. PMID 1825460 DOI: 10.1002/Ana.410290119 |
0.418 |
|
| 1991 |
Pifl C, Schingnitz G, Hornykiewicz O. Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the regional distribution of brain monoamines in the rhesus monkey. Neuroscience. 44: 591-605. PMID 1754053 DOI: 10.1016/0306-4522(91)90080-8 |
0.747 |
|
| 1990 |
Pifl C, Bertel O, Schingnitz G, Hornykiewicz O. Extrastriatal dopamine in symptomatic and asymptomatic rhesus monkeys treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Neurochemistry International. 17: 263-70. PMID 20504626 DOI: 10.1016/0197-0186(90)90148-M |
0.737 |
|
| 1990 |
Kish SJ, Kleinert R, Minauf M, Gilbert J, Walter GF, Slimovitch C, Maurer E, Rezvani Y, Myers R, Hornykiewicz O. Brain neurotransmitter changes in three patients who had a fatal hyperthermia syndrome. The American Journal of Psychiatry. 147: 1358-63. PMID 2133042 |
0.378 |
|
| 1990 |
Kish S, Dozic S, Deck J, Shannak K, Hornykiewicz O. BRAIN NORADRENERGIC CHANGES IN A PATIENT WITH WILSONʼS DISEASE Journal of Neuropathology and Experimental Neurology. 49: 280. DOI: 10.1097/00005072-199005000-00064 |
0.301 |
|
| 1989 |
Hornykiewicz O. Ageing and neurotoxins as causative factors in idiopathic Parkinson's disease--a critical analysis of the neurochemical evidence. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 13: 319-28. PMID 2664888 DOI: 10.1016/0278-5846(89)90121-8 |
0.472 |
|
| 1988 |
Kish SJ, Shannak K, Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. The New England Journal of Medicine. 318: 876-80. PMID 3352672 DOI: 10.1056/Nejm198804073181402 |
0.53 |
|
| 1988 |
Pifl C, Schingnitz G, Hornykiewicz O. The neurotoxin MPTP does not reproduce in the rhesus monkey the interregional pattern of striatal dopamine loss typical of human idiopathic Parkinson's disease. Neuroscience Letters. 92: 228-33. PMID 3263594 DOI: 10.1016/0304-3940(88)90066-3 |
0.756 |
|
| 1988 |
Pifl C, Hornykiewicz O. Postsynaptic dopamine agonist properties of B-HT 920 as revealed by concomitant D-1 receptor stimulation. European Journal of Pharmacology. 146: 189-91. PMID 3258244 DOI: 10.1016/0014-2999(88)90504-3 |
0.649 |
|
| 1988 |
Gilbert JJ, Kish SJ, Chang LJ, Morito C, Shannak K, Hornykiewicz O. Dementia, parkinsonism, and motor neuron disease: neurochemical and neuropathological correlates. Annals of Neurology. 24: 688-91. PMID 2904794 DOI: 10.1002/Ana.410240518 |
0.32 |
|
| 1988 |
Pifl C, Pichler L, Kobinger W, Hornykiewicz O. The dopamine autoreceptor agonist, B-HT 920, preferentially reduces brain dopamine release in vivo: biochemical indices of brain dopamine, noradrenaline and serotonin in ventriculocisternal perfusates in the cat. European Journal of Pharmacology. 153: 33-44. PMID 2463928 DOI: 10.1016/0014-2999(88)90585-7 |
0.667 |
|
| 1987 |
Kish S, Rajput A, Gilbert J, Rozdilsky B, Chang LJ, Shannak K, Hornykiewicz O. GABA-dopamine relationship in Parkinson's disease striatum. Advances in Neurology. 45: 75-7. PMID 3825737 |
0.415 |
|
| 1987 |
Pichler L, Pifl C, Hornykiewicz O, Kobinger W. The dopamine autoreceptor agonist B-HT 920 inhibits in vivo dopamine release into the cerebroventricular system of cats. European Journal of Pharmacology. 135: 239-42. PMID 2884121 DOI: 10.1016/0014-2999(87)90618-2 |
0.72 |
|
| 1987 |
Kish SJ, Shannak K, Hornykiewicz O. Elevated serotonin and reduced dopamine in subregionally divided Huntington's disease striatum. Annals of Neurology. 22: 386-9. PMID 2445259 DOI: 10.1002/Ana.410220318 |
0.524 |
|
| 1986 |
Hinzen D, Hornykiewicz O, Kobinger W, Pichler L, Pifl C, Schingnitz G. The dopamine autoreceptor agonist B-HT 920 stimulates denervated postsynaptic brain dopamine receptors in rodent and primate models of Parkinson's disease: a novel approach to treatment. European Journal of Pharmacology. 131: 75-86. PMID 3816949 DOI: 10.1016/0014-2999(86)90517-0 |
0.673 |
|
| 1986 |
Kish SJ, Rajput A, Gilbert J, Rozdilsky B, Chang LJ, Shannak K, Hornykiewicz O. Elevated gamma-aminobutyric acid level in striatal but not extrastriatal brain regions in Parkinson's disease: correlation with striatal dopamine loss. Annals of Neurology. 20: 26-31. PMID 2874765 DOI: 10.1002/Ana.410200106 |
0.37 |
|
| 1985 |
Kish SJ, Morito C, Hornykiewicz O. Glutathione peroxidase activity in Parkinson's disease brain. Neuroscience Letters. 58: 343-6. PMID 4047494 DOI: 10.1016/0304-3940(85)90078-3 |
0.348 |
|
| 1985 |
Hornykiewicz O. [The life history of brain dopamine]. Wiener Klinische Wochenschrift. 97: 350-4. PMID 2986364 |
0.527 |
|
| 1985 |
Kish SJ, Chang LJ, Mirchandani L, Shannak K, Hornykiewicz O. Progressive supranuclear palsy: relationship between extrapyramidal disturbances, dementia, and brain neurotransmitter markers. Annals of Neurology. 18: 530-6. PMID 2416269 DOI: 10.1002/Ana.410180504 |
0.329 |
|
| 1984 |
Kish SJ, Shannak KS, Rajput AH, Gilbert JJ, Hornykiewicz O. Cerebellar norepinephrine in patients with Parkinson's disease and control subjects. Archives of Neurology. 41: 612-4. PMID 6721735 DOI: 10.1001/Archneur.1984.04210080020007 |
0.341 |
|
| 1981 |
Lee T, Seeman P, Hornykiewicz O, Bilbao J, Deck J, Tourtellotte WW. Parkinson's disease: low density and presynaptic location of D3 dopamine receptors. Brain Research. 212: 494-8. PMID 7225883 DOI: 10.1016/0006-8993(81)90484-4 |
0.416 |
|
| 1981 |
Sperk G, Berger M, Hörtnagl H, Hornykiewicz O. Kainic acid-induced changes of serotonin and dopamine metabolism in the striatum and substantia nigra of the rat. European Journal of Pharmacology. 74: 279-86. PMID 6170518 DOI: 10.1016/0014-2999(81)90046-7 |
0.343 |
|
| 1981 |
Lloyd KG, Hornykiewicz O, Davidson L, Shannak K, Farley I, Goldstein M, Shibuya M, Kelley WN, Fox IH. Biochemical evidence of dysfunction of brain neurotransmitters in the Lesch-Nyhan syndrome. The New England Journal of Medicine. 305: 1106-11. PMID 6117011 DOI: 10.1056/Nejm198111053051902 |
0.364 |
|
| 1981 |
Sperk G, Berger M, Hornykiewicz O. Influence of kainic acid lesions on turnover of dopamine and serotonin in the striatum Naunyn-Schmiedeberg's Archives of Pharmacology. 316: 264. |
0.385 |
|
| 1980 |
Hornykiewicz O. [Brain dopamine and brain disorders - and what we have learned from these studies (author's transl)]. Wiener Klinische Wochenschrift. 92: 740-3. PMID 7467350 |
0.451 |
|
| 1980 |
Farley IJ, Shannak KS, Hornykiewicz O. Brain monoamine changes in chronic paranoid schizophrenia and their possible relation to increased dopamine receptor sensitivity. Advances in Biochemical Psychopharmacology. 21: 427-33. PMID 6155058 |
0.3 |
|
| 1979 |
Fariello RG, Hornykiewicz O. Substantia nigra and pentylenetetrazol threshold in rats: correlation with striatal dopamine metabolism. Experimental Neurology. 65: 202-8. PMID 262229 DOI: 10.1016/0014-4886(79)90260-7 |
0.379 |
|
| 1978 |
Price KS, Farley IJ, Hornykiewicz O. Neurochemistry of Parkinson's disease: relation between striatal and limbic dopamine. Advances in Biochemical Psychopharmacology. 19: 293-300. PMID 696462 |
0.486 |
|
| 1978 |
Lee T, Seeman P, Rajput A, Farley IJ, Hornykiewicz O. Receptor basis for dopaminergic supersensitivity in Parkinson's disease. Nature. 273: 59-61. PMID 692671 DOI: 10.1038/273059a0 |
0.325 |
|
| 1978 |
Shibuya M, Fariello R, Farley IJ, Price KS, Lloyd KG, Hornykiewicz O. Cobalt injections into the substantia nigra of the rat: effects on behavior and dopamine metabolism in the striatum. Experimental Neurology. 58: 486-99. PMID 620704 DOI: 10.1016/0014-4886(78)90103-6 |
0.362 |
|
| 1978 |
Hornykiewicz O. Psychopharmacological implications of dopamine and dopamine antagonists: a critical evaluation of current evidence. Neuroscience. 3: 773-83. PMID 30919 DOI: 10.1016/0306-4522(78)90030-1 |
0.452 |
|
| 1977 |
Farley IJ, Price KS, Hornykiewicz O. Dopamine in thelimbic regions of the human brain: normal and abnormal. Advances in Biochemical Psychopharmacology. 16: 57-64. PMID 883559 |
0.451 |
|
| 1977 |
Hornykiewicz O. Psychopharmacological implications of dopamine and dopamine antagonists: a critical evaluation of current evidence. Annual Review of Pharmacology and Toxicology. 17: 545-59. PMID 17361 DOI: 10.1146/annurev.pa.17.040177.002553 |
0.452 |
|
| 1975 |
Hornykiewicz O. Parkinsonism induced by dopaminergic antagonists. Advances in Neurology. 9: 155-64. PMID 1096571 |
0.435 |
|
| 1975 |
Hornykiewicz O. Brain monoamines and parkinsonism. National Institute On Drug Abuse Research Monograph Series. 13-21. PMID 787796 |
0.468 |
|
| 1975 |
Lloyd KG, Davidson L, Hornykiewicz O. The neurochemistry of Parkinson's disease: effect of L-dopa therapy. The Journal of Pharmacology and Experimental Therapeutics. 195: 453-64. PMID 489 |
0.381 |
|
| 1975 |
Hornykiewicz O. Abnormalities of nigrostriatal dopamine metabolism: neurochemical, morphological and clinical correlations | NEUROPSYCHOPHARMACOLOGY. PROCEEDINGS OF THE IX CONGRESS OF THE COLLEGIUM INTERNATIONALE NEUROPSYCHOPHARMACOLOGICUM, PARIS, 7-12 JULY, 1974 Excerpta Medica, Amsterdam. 524-529. |
0.346 |
|
| 1974 |
Kuschinsky K, Hornykiewicz O. Effects of morphine on striatal dopamine metabolism: possible mechanism of its opposite effect on locomotor activity in rats and mice. European Journal of Pharmacology. 26: 41-50. PMID 4598755 DOI: 10.1016/0014-2999(74)90072-7 |
0.323 |
|
| 1974 |
Hornykiewicz O. Some remarks concerning the possible role of brain monoamines (dopamine, noradrenaline, serotonin) in mental disorders. Journal of Psychiatric Research. 11: 249-53. PMID 4282386 DOI: 10.1016/0022-3956(74)90098-3 |
0.351 |
|
| 1974 |
Hornykiewicz O. Metabolism of dopamine and l-dopa in human brain Biochemical Pharmacology. 23: 917-923. DOI: 10.1016/0006-2952(74)90162-2 |
0.34 |
|
| 1973 |
Hornykiewicz O. Dopamine in the basal ganglia. Its role and therapeutic implications (including the clinical use of L-DOPA). British Medical Bulletin. 29: 172-8. PMID 4356552 |
0.348 |
|
| 1973 |
Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. Journal of the Neurological Sciences. 20: 415-55. PMID 4272516 DOI: 10.1016/0022-510X(73)90175-5 |
0.477 |
|
| 1973 |
Hornykiewicz O. Metabolism of dopamine and L dopa in the human brain Life Sciences. 13: 1xxiv-1xxvi. |
0.34 |
|
| 1973 |
Hornykiewicz O. Metabolism of dopamine and L-dopa in the human brain Life Sciences. 13: lxxiv-lxxvi. |
0.34 |
|
| 1972 |
Kuschinsky K, Hornykiewicz O. Morphine catalepsy in the rat: relation to striatal dopamine metabolism. European Journal of Pharmacology. 19: 119-22. PMID 5065530 |
0.331 |
|
| 1972 |
Bieger D, Hornykiewicz O. Dopamine in the earthworm, Lumbricus terrestris: enhancement of rhythmic contractile activity. Neuropharmacology. 11: 745-8. PMID 4670601 DOI: 10.1016/0028-3908(72)90085-8 |
0.427 |
|
| 1972 |
Hornykiewicz O. Dopamine and extrapyramidal motor function and dysfunction. Research Publications - Association For Research in Nervous and Mental Disease. 50: 390-415. PMID 4561070 |
0.368 |
|
| 1971 |
Hornykiewicz O. Neurochemical pathology and pharmacology of brain dopamine and acetylcholine: rational basis for the current drug treatment of Parkinsonism. Contemporary Neurology Series. 8: 33-65. PMID 5162181 |
0.385 |
|
| 1971 |
Davidson L, Lloyd K, Dankova J, Hornykiewicz O. L-DOPA treatment in Parkinson's disease: effect on dopamine and related substances in discrete brain regions. Experientia. 27: 1048-9. PMID 5116129 |
0.397 |
|
| 1970 |
Hornykiewicz O. The metabolism of brain dopamine in human parkinsonism. Rivista Di Patologia Nervosa E Mentale. 91: 281-6. PMID 5525774 |
0.423 |
|
| 1968 |
Hornykiewicz O, Lisch HJ, Springer A. Homovanillic acid in different regions of the human brain: attempt at localizing central dopamine fibres. Brain Research. 11: 662-71. PMID 5712014 |
0.356 |
|
| 1968 |
Lisch HJ, Aigner A, Hornykiewicz O. [Dopamine metabolism in the rabbit caudate nucleus following partial inhibition of brain monoamine oxidase by nialamide]. Naunyn-Schmiedebergs Archiv Fã¼R Experimentelle Pathologie Und Pharmakologie. 261: 289-98. PMID 4235430 |
0.393 |
|
| 1968 |
Lisch H, Aigner A, Hornykiewicz O. Dopamin-Stoffwechsel im Nucleus caudatus des Kaninchens nach partieller Hemmung der Gehirn-Monoaminoxydase mittels Nialamid Naunyn-Schmiedebergs Archiv F�R Pharmakologie Und Experimentelle Pathologie. 261: 289-298. DOI: 10.1007/BF00537174 |
0.434 |
|
| 1967 |
Hornykiewicz O, Lisch HJ. [Monoamine oxidase inhibitors and dopamine-(3-hydroxytyramine-) metabolism in the brain]. Naunyn-Schmiedebergs Archiv Fã¼R Experimentelle Pathologie Und Pharmakologie. 257: 30. PMID 4231842 |
0.366 |
|
| 1967 |
Hornykiewicz O, Lisch H-. Monoaminoxydase-Hemmer und Dopamin-(3-Hydroxytyramin-) Stoffwechsel im Gehirn Naunyn-Schmiedebergs Archiv F�R Pharmakologie Und Experimentelle Pathologie. 257: 30-30. DOI: 10.1007/BF00537404 |
0.471 |
|
| 1967 |
Hornykiewicz O, Lisch H, Denk H. Wirkung von Chlorpromazin (CPZ) und ?-Methyl-p-Tyrosin (?MpT) auf den Dopamin-(DA) Gehalt des nigro-stri�ren Systems Naunyn-Schmiedebergs Archiv F�R Pharmakologie Und Experimentelle Pathologie. 257: 289-290. DOI: 10.1007/BF00537056 |
0.383 |
|
| 1966 |
Hornykiewicz O. Dopamine (3-hydroxytyramine) and brain function. Pharmacological Reviews. 18: 925-64. PMID 5328389 |
0.4 |
|
| 1965 |
Bernheimer H, Hornykiewicz O. [Decreased homovanillic acid concentration in the brain in parkinsonian subjects as an expression of a disorder of central dopamine metabolism]. Klinische Wochenschrift. 43: 711-5. PMID 5826380 DOI: 10.1007/BF01707066 |
0.31 |
|
| 1965 |
Bernheimer H, Hornykiewicz O. Wirkung von Phenothiazinderivaten auf den Dopamin-(=3-Hydroxytyramin-)Stoffwechsel im Nucleus caudatus Naunyn-Schmiedeberg's Archiv F�R Experimentelle Pathologie Und Pharmakologie. 251: 135-136. DOI: 10.1007/BF00420105 |
0.453 |
|
| 1964 |
Bernheimer H, Hornykiewicz O. Das Verhalten des Dopamin-Metaboliten Homovanillinsäure im Gehirn von normalen und Parkinson-kranken Menschen Naunyn-Schmiedebergs Archiv FüR Experimentelle Pathologie Und Pharmakologie. 247: 305-306. DOI: 10.1007/BF02308399 |
0.513 |
|
| 1964 |
Seitelberger F, Petsche H, Bernheimer H, Hornykiewicz O. Verhalten des Dopamins (=3-Hydroxytyramin) im Nucleus caudatus nach elektrischer Koagulation des Globus pallidus The Science of Nature. 51: 314-315. DOI: 10.1007/Bf00624184 |
0.396 |
|
| 1963 |
HORNYKIEWICZ O. [The tropical localization and content of noradrenalin and dopamine (3-hydroxytyramine) in the substantia nigra of normal persons and patients with Parkinson's disease]. Wiener Klinische Wochenschrift. 75: 309-12. PMID 13954967 |
0.456 |
|
| 1962 |
HORNYKIEWICZ O. [Dopamine (3-hydroxytyramine) in the central nervous system and its relation to the Parkinson syndrome in man]. Deutsche Medizinische Wochenschrift (1946). 87: 1807-10. PMID 14448985 DOI: 10.1055/s-0028-1114024 |
0.442 |
|
| 1962 |
Bernheimer H, Hornykiewicz O. Monoaminoxydase-Hemmer und Dopamin-, Noradrenalin- und 5-Hydroxytryptamin-Stoffwechsel im Gehirn Parkinson-kranker Menschen Naunyn-Schmiedeberg's Archiv F�R Experimentelle Pathologie Und Pharmakologie. 245: 52-52. DOI: 10.1007/BF00260041 |
0.526 |
|
| 1962 |
Bernheimer H, Hornykiewicz O. Das Verhalten einiger Enzyme im Gehirn normaler und Parkinson-kranker Menschen Naunyn-Schmiedeberg's Archiv F�R Experimentelle Pathologie Und Pharmakologie. 243: 295-296. DOI: 10.1007/BF00244849 |
0.344 |
|
| 1961 |
Hornykiewicz O, Ehringer H, Lechner K. Beeinflussung der Iproniazidwirkung auf die Katecholamine und das 5-Hydroxytryptamin des Rattenhirnes durch Chlorpromazin Naunyn-Schmiedebergs Archiv FüR Experimentelle Pathologie Und Pharmakologie. 241: 198-199. DOI: 10.1007/BF02433556 |
0.3 |
|
| 1960 |
EHRINGER H, HORNYKIEWICZ O. [Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system]. Klinische Wochenschrift. 38: 1236-9. PMID 13726012 DOI: 10.1007/BF01485901 |
0.37 |
|
| 1959 |
HOLZER G, HORNYKIEWICZ O. [On dopamine (hydroxytyramine) metabolism in the rat brain]. Naunyn-Schmiedebergs Archiv Fã¼R Experimentelle Pathologie Und Pharmakologie. 237: 27-33. PMID 14402902 |
0.331 |
|
| 1959 |
Holzer G, Hornykiewicz O. �ber den Dopamin-(Hydroxytyramin-)Stoffwechsel im Gehirn der Ratte Naunyn-Schmiedeberg's Archiv F�R Experimentelle Pathologie Und Pharmakologie. 237. DOI: 10.1007/BF00244557 |
0.47 |
|
| 1958 |
BORN GV, HORNYKIEWICZ O, STAFFORD A. The uptake of adrenaline and noradrenaline by blood platelets of the pig. British Journal of Pharmacology and Chemotherapy. 13: 411-4. PMID 13618545 |
0.421 |
|
| 1958 |
HORNYKIEWICZ O, OBENAUS H. [The effect of lysergic acid diethylamide on the hypotensive effects of dopamine and adrenalin]. Wiener Klinische Wochenschrift. 70: 948-9. PMID 13616317 |
0.39 |
|
| 1957 |
BORN GV, HORNYKIEWICZ O. The proportionality between the uptake of adrenaline by blood platelets and their content of adenosine triphosphate. The Journal of Physiology. 136: 30P-1P. PMID 13429505 |
0.423 |
|
| Show low-probability matches. |